Latest Live News: India has approved Merck's Covid-19 pill and two more vaccines for emergency use as the world's second most populous country braces for a possible spike in coronavirus cases due to the rapidly spreading Omicron variant.
Molnupiravir will be manufactured in India by 13 companies for restricted use under emergency situation for treatment of adult patients with Covid-19, said Health Minister Mansukh Mandaviya on Tuesday.
Merck's anti-viral pill molnupiravir was authorised by the United States last week for certain high-risk adult patients and has been shown to reduce hospitalisations and deaths by around 30 per cent in a clinical trial.
Two other Covid-19 vaccines, Serum Institute of India's version of Novavax Inc's shot, Covovax, and homegrown drugmaker Biological E's Corbevax were also granted emergency use approval, Mandaviya said on Twitter.
New restrictions with a "yellow alert" will take effect in Delhi amid a rise in Covid cases, Chief Minister Arvind Kejriwal today said, adding that a "detailed order" will be shared soon.
CATCH ALL THE LIVE UPDATES